Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Authors:
Open Access
- 22 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 34 (10) , 2281-2285
Abstract
Metabolomic profiling has identified, sarcosine, a derivative of the amino acid glycine, as an important metabolite involved in the etiology or natural history of prostate cancer. We examined the association between serum sarcosine levels and risk of prostate cancer in 1122 cases (813 non-aggressive and 309 aggressive) and 1112 controls in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Sarcosine was quantified using high-throughput liquid chromatography–mass spectrometry. A significantly increased risk of prostate cancer was observed with increasing levels of sarcosine (odds ratio [OR] for the highest quartile of exposure [Q4] versus the lowest quartile [Q1] = 1.30, 95% confidence interval [CI]: 1.02, 1.65; P -trend 0.03). When stratified by disease aggressiveness, we observed a stronger association for non-aggressive cases (OR for Q4 versus Q1 = 1.44, 95% CI: 1.11, 1.88; P -trend 0.006) but no association for aggressive prostate cancer (OR for Q4 versus Q1 = 1.03, 95% CI: 0.73, 1.47; P -trend 0.89). Although not statistically significant, temporal analyses showed a stronger association between sarcosine and prostate cancer for serum collected closer to diagnosis, suggesting that sarcosine may be an early biomarker of disease. Interestingly, the association between sarcosine and prostate cancer risk was stronger among men with diabetes (OR = 2.66, 95% CI: 1.04, 6.84) compared with those without reported diabetes (OR = 1.23, 95% CI: 0.95–1.59, P -interaction = 0.01). This study found that elevated levels of serum sarcosine are associated with an increased prostate cancer risk and evidence to suggest that sarcosine may be an early biomarker for this disease.Keywords
This publication has 34 references indexed in Scilit:
- LINE-1 Hypomethylation in Noncancerous Esophageal Mucosae is Associated with Smoking HistoryAnnals of Surgical Oncology, 2012
- Cigarette Smoking and Prostate Cancer in a Prospective US Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCancer Causes & Control, 2008
- Endogenous sex hormones and the risk of prostate cancer: A prospective studyInternational Journal of Cancer, 2008
- Hormonal profile of diabetic men and the potential link to prostate cancerCancer Causes & Control, 2008
- A Meta-analysis of Diabetes Mellitus and the Risk of Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinomaCancer, 2005
- Diabetes mellitus and risk of prostate cancer: a meta-analysisDiabetologia, 2004
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000